Digoxin and digoxin-like immunoreactive factors (DLIF) modulate the release of pro-inflammatory cytokines

Inflammation Research

Volumn 57, Issue 11, 2008, Pages 519-523

  Ihenetu, K ^a   Espinosa, R ^a   De Leon, R ^a   Planas, G ^b   Perez Pinero, A ^b   Waldbeser, L ^a  

^a TEXAS A AND M UNIVERSITY CORPUS CHRISTI   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Digoxin like immunoreactive factor; DLIF; IL 10; IL 6; IL 8; Interleukin 10; Interleukin 6; Interleukin 8; Lipopolysaccharides; LPS; PBMC; Peripheral blood mononuclear cell; TNF alpha; Tumor necrosis factor alpha

Indexed keywords

ANTIBODY; CYTOKINE; DIGITALIS LIKE FACTOR; DIGOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; STIMULATION;

CARDENOLIDES; CYTOKINES; DIGOXIN; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NF-KAPPA B; SAPONINS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149121106     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-008-7249-9     Document Type: Article

References (27)

1. Chronic disease reports: mortality trends: United States, 1979-1986. MMWR Morb Mortal Wkly Rep1989; 38:189-193.
2. Mortality patterns: United States, 1987. MMWR Morb Mortal Wkly Rep 1990; 39: 193-196, 201.
3. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241.
4. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1999; 72: 561-566.
5. Ankrust P, Ueland T, Lien E. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83: 376-382.
6. Schoner W, Scheiner-Bobis G. Endogenous cardiac glycosides: Hormones using sodium pump as signal transduction. Sem Nephrol 2005; 25: 343-351.
7. Bristow MR. Tumor necrosis factor-alpha and cardiomyopathy. Circulation 1998; 97: 1340-1341.
8. Ihenetu K, Molleman A, Parsons M, Whelan C. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells. Eur J Pharmacol 2003; 464: 207-215.
9. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995; 92: 1487-1493.
10. Bryant D, Becker L, Richardson J. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor alpha. Circulation 1998; 97: 1375-1381.
11. Borkurst B, Kribbs SB, Cribb FJ, Jr. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation1998; 97: 1382-1391.
12. Joyce DA, Gibbons DP, Green P. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin 4 have contrasting effects on the release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 1994; 24: 2699-2705.
13. Skou JC, Esmann M. The Na+,K+-ATPase. J Bioenerg Biomembr 1992; 24: 249-261.
14. Schoner W, Scheiner-Bobis G. Endogenous cardiac glycosides: Hormones using sodium pump as signal transduction. Sem Nephrol 2005; 25: 343-351.
15. Schneider R, Wray V, Nimtz M, Lehman WD, Kirch U, Antolovia R, Schoner W. Bovine adrenals contain in addition to ouabain, a second inhibitor of sodium pump. J Biol Chem 1998; 273: 784-792.
16. Ihenetu K, Qazzaz HM, Crespo F, Fernandez-Botran R, Valdes R Jr. Digoxin-Like immunoreactive factors induce apoptosis in human acute T-cell lymphobastic leukemia. Clin Chem 2007; 53: 1315-1322
17. Qazzaz HMH, Valdes R Jr. Simultanous isolation of endogenous digoxin-like immunoreactive factor (DLIF) and ouabain-like factor (OLF) from mammalian tissue. Arch Biochem Biophys 1996; 328: 193-200.
18. Honda O, Naito Y, Takagi T, Shimozawa M, Kokura S, Yoshida N. Tumor necrosis factor-alpha-induced cytokine neutrophil chemoattractant-1 (CINC-1) production by rat gastric epithelial cells:role of reactive oxygen species and nuclear factor-kappa B. J Pharmacol Exp Ther 2004; 309: 670-676.
19. Skayian Y, Kreydiyyeh SI. Tumor necrosis factor alpha alters Na, K-ATPase activity in rat cardiac myocytes: Involvement of NF-kB, AP-1 and PGE2. Life Sci 2006; 80: 173-180
20. Lichstein D, Gati I, Samuelou S, Berson D, Rosenman Y, Landau L, Deutsch J. Identification of digitalis-like compounds in human caractous lenses. Eur J Biochem 1993; 216: 261-8.
21. + pumps [Review]. Miner Electrolyte Metab 1996; 22: 303-10.
22. Kometiani P, Liu L, Askari A, Digitalis-induced signaling by Na/K-ATPase in human breast cancer cells. Mol Pharmacol 2005; 67: 929-936.
23. Matsumori A, Nunokawa Y, Yamaki A, Yamamoto K, Hwang M, Miyamoto T, Hara M, Nishio R, Kitmara-Inenga K, Ono K. Suppresión of cytokines and nitric oxide production, and protection against lethal endothoxemia and viral myocarditis by a new NF-κB inhibitor. Eur J Heart Failure 2004; 9: 137-144
24. Baeuerle, P.A.and Henkel, T.Function and activation of NF-kB in the immune system. Annu Rev Immunol 1994; 12: 141.
25. Baldwin, A.S. Jr. The NF-kB and IkB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683,
26. Bauerle, P.A. and Baichwal, V. R. NF-kB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 1997; 65: 111-137.
27. Baichwal, V.R. and Baeuerle. P.A. Apoptosis: activate NF-kB or die? Curr Biol 1997; 7: R94-R96.